Defects in pancreatic ␤-cell function contribute to the development of type 2 diabetes, a polygenic disease that is characterized by insulin resistance and compromised insulin secretion. Hepatocyte nuclear factors (HNFs) -1␣, -3␤, -4␣, and Pdx-1 contribute in the complex transcriptional circuits within the pancreas that are involved in ␤-cell development and function. In mice, a heterozygous mutation in Pdx-1 alone, but not Hnf-1␣ ؉/؊ , Hnf-3␤ ؉/؊ , or Hnf-4␣ ؉/؊ , causes impaired glucose-stimulated insulin secretion in mice. To investigate the possible functional relationships between these transcription factors on ␤-cell activity in vivo, we generated mice with the following combined heterozygous mutations: Pdx-
hepatocyte nuclear factors ͉ diabetes mellitus ͉ insulin secretion ͉ pancreatic islets G enetic and biochemical studies in humans and mice have identified many key transcription factors that are involved in controlling pancreas development and ␤Ϫcell function in the adult islet (see ref. 1 for review). These factors have in common an islet-enriched expression pattern during pancreatic development, although each [e.g., hepatocyte nuclear factors (HNFs)] are also expressed in extrapancreatic tissues (e.g., intestine, liver, brain͞neurons, and kidney). Heterozygous mutations in a subset of these genes, including HNF-4␣, HNF-1␣, PDX-1, HNF-1␤, and BETA2, are specifically associated with a form of type 2 diabetes, termed maturity-onset diabetes of the young (MODY), that is characterized by an early disease onset (usually Ͻ25 years), autosomal dominant inheritance, and a primary defect in insulin secretion (see ref. 2 for review). There is increasing evidence that these and other islet-enriched transcription factors (e.g., Nkx2.2, Nkx6.1, Pax-4, and Pax-6) form an integrated regulatory network in the ␤-cell that is critical for normal glucose-stimulated insulin secretion (3, 4) .
The ␤-cell transcriptional network is organized in a hierarchical manner. The upstream regulator of the network may be HNF-3␤, a protein in the Forkhead transcription factor family. Although little is known about how HNF-3␤ activates transcription in pancreatic ␤-cell development and function, it may promote transcription in a manner similar to its action in liver and initiate the opening of the chromatin and transcription complex assembly (5, 6) . HNF-3␤ and HNF-1␤ regulate HNF-4␣ and HNF-1␣ gene expression in extrapancreatic tissues (7) (8) (9) , but it is unclear whether this is also true in the pancreas. In ␤-cells, HNF-3␤ and HNF-1␣ may directly regulate PDX-1 gene transcription (10) (11) (12) (13) (14) (15) . In addition, HNF-1␣ and HNF-4␣ autoregulate each other's expression (14, 16) . Interestingly, in contrast to humans, only heterozygous Pdx-1 mutants but not Hnf-4␣, Hnf-1␣, Hnf-1␤, or Beta2 induce a diabetic phenotype in mice, presumably because of the direct importance of Pdx-1 in regulating glucose transporter 2 (Glut-2), glucokinase (Gck), and insulin gene expression. Collectively, Hnf-1␤, Hnf-3␤, Hnf-4␣, and Pdx-1 appear to contribute in controlling transcription of a number of key genes involved in glucose metabolism in the ␤-cell, including Glut-2, Gck, the liver isoform of pyruvate kinase (L-Pk), aldolase B (aldo-B), and insulin (17) .
Because of the importance of HNF-1␤, HNF-3␤, HNF-4␣, and PDX-1 in ␤-cell function, we sought to determine whether functional interactions between these islet-enriched transcription factors would be revealed upon combining heterozygous mutations of these genes in mice. Using this genetic approach, we show that Pdx-1 acts in concert with Hnf-1␣ and Hnf-3␤ to control whole body glucose levels and to maintain normal islet morphology.
Methods
Animals and Genotyping. All animal models were maintained in C57͞B6 background and were housed in the Laboratory Animal Research Center (LARC), a pathogen-free animal facility at the Rockefeller University. The animals were maintained on a 12 h light͞dark cycle and fed a standard rodent chow. Genotyping was performed on DNA isolated from 3-week-old mice by PCR. The primer sequences of the wild-type and mutant alleles are available upon request.
Glucose Tolerance Tests and Insulin Release. Mice were fasted overnight for 12 h and then injected i.p. with glucose (2 g͞kg body weight). Venous blood was obtained from the tail vein at 0, 15, 30, 60, and 120 min after the injection. Blood glucose was measured with an automated glucometer (Encore, Bayer).
For insulin release, glucose (3 g͞kg body weight) was injected i.p., and venous blood was collected at 0, 2, 5, 15, 30, 60, and 120 min in heparin-containing tubes and centrifuged, and the plasma was stored at Ϫ20°C. Insulin levels were measured with an ultrasensitive ELISA (Crystal Chemical, Chicago).
Metabolic Studies. Plasma glucagon levels were measured with an RIA kit (Linco, St. Charles, MO) using rat glucagon standards. Cholesterol, bile acid, triglyceride, glycerol, and fatty acids in the plasma were measured by enzyme assays (Sigma).
Isolation of Islet RNA. Pancreatic islets from 5-month-old mice were isolated by collagenase digestion and differential centrifugation through Ficoll gradients. Islets were cultured overnight in RPMI medium 1640 (Life Technologies) supplemented with 10% FCS and 11.1 mM glucose. Total RNA was then extracted from double hand-picked islets by using Trizol reagent (Life Technologies). Contaminating genomic DNA was removed by using 10 units of RNase-free DNase I (Boehringer Mannheim) per 5 g of RNA.
Reverse Transcriptase (RT)-PCR. RT-PCR was carried out for semiquantitative gene expression analysis as described (18) . cDNAs were synthesized by using Moloney murine leukemia virus RT (Stratagene) with dNTPs and random hexamer primers (Stratagene). These cDNAs served as the PCR template for reactions run in the presence of specific primers, dNTPs, and Taq DNA polymerase at annealing temperatures between 60°C and 65°C. Typically, 20-28 cycles were run to maintain the amplification within the linear range. The intra-assay coefficient of variation of the RT-PCR was Ͻ5%. The primer sequences used for PCR are available upon request.
Immunohistochemistry and Immunofluorescence Analysis. Immunof luorescence analysis was performed on 5-m paraffinembedded pancreatic sections from 5-month-old mice by using conditions described previously (14) . The primary guinea pig anti-insulin and rabbit anti-glucagon antibodies (Linco) were used at 1:600 and 1:300 dilution in PBS, respectively. Rhodamine red-conjugated donkey anti-guinea pig (Jackson ImmunoResearch) and Alexa Fluor 488-conjugated donkey anti-rabbit antibodies (Molecular Probes) were incubated with the primaryantibody-treated samples at dilutions of 1:100 and 1:600 in PBS, respectively. Sections were washed three times in PBS between each incubation and then mounted by using the Prolong Antifade kit (Molecular Probes). Image analysis was performed on a Zeiss LSM 510 confocal laser scanning microscope with dual detectors and an argon͞krypton laser for simultaneous scanning of the two different fluorochromes. Images were acquired by using the LSM 510 software package (Zeiss).
Morphometric Analysis. The pancreata were fixed in paraformaldehyde and stained for insulin and glucagon as described above. Sections (7 m) through the entire pancreas were taken, and every sixth section was used for morphometric analysis. At least 288 nonoverlapping images (pixel size 0.88 m) were scanned by using a confocal laser scanning microscope (Zeiss LSM 510). The morphometry parameters were analyzed by using the META-MORPH software package (Universal Imaging, Media, PA). The areas covered by cells stained by insulin or glucagon were integrated by using stained objects that are greater than 3 pixels in size.
Statistical Analysis. All values indicated are expressed as mean Ϯ SE unless indicated otherwise. Statistical analysis was carried out with a two-tailed Student's unpaired t test, and the null hypothesis was rejected at the 0.05 level.
Results

Generation and Metabolic Characterization of Mutant Mice.
The combined heterozygous Hnf-1␣
ϩ/Ϫ ͞Hnf-4␣
, and Pdx-1 ϩ/Ϫ ͞Hnf-1␣
ϩ/Ϫ mutant mice were generated by intercrossing mice heterozygous for each mutation. The effect of animals at 1 month of age but developed a progressively decreased ability to clear glucose by 3 and 4 months (Fig. 1B) (Fig. 2 A) . Pdx-1 ϩ/Ϫ ͞Hnf-3␤ ϩ/Ϫ mice also lost the first-phase insulin response. However, insulin levels were not significantly different from Wt at the 2-h point (Fig. 2B) . These results suggest that synergistic interactions between Hnf-1␣, Hnf-3␤, and Pdx-1 profoundly affect insulin secretion and glucose homeostasis in mice.
Because Hnf-1␣, Hnf-3␤, and Hnf-4␣ are also expressed in liver and pancreatic ␣-cells, we investigated the levels of a number of surrogate markers that can influence glucose ho- meostasis. Fasting serum insulin, glucagon, fatty acid, glycerol, cholesterol, and bile acid levels in single and combined heterozygous mutant mice were indistinguishable from those in Wt mice (see Table 1 , which is published as supporting information on the PNAS web site, www.pnas.org). These data further support the finding that impaired glucose homeostasis in Pdx-1 ϩ/Ϫ ͞Hnf-1␣ ϩ/Ϫ and Pdx-1 ϩ/Ϫ ͞Hnf-3␤ mice were performed to determine whether the loss in ␤-cell function was associated with a reduction in islet mass or morphology. Pancreatic sections from 5-month-old mice were analyzed with insulin and glucagon antibodies to visualize ␤-and ␣-cells, respectively. We did not detect a significant difference in total pancreatic islet area or in the ␣-to ␤-cell ratios between Wt and mutant islets (see Table  2 , which is published as supporting information). Thus, it is unlikely that a reduction ␤-cell size͞number leads to the diabetic phenotype in double-mutant mice. However, the characteristic islet architecture, specifically the confinement of ␣-cells to the periphery of the islet, was disorganized in Pdx-1 ϩ/Ϫ ͞Hnf-3␤ (Fig. 3) . Even though ␣-cells were scattered throughout the islet in the mutants, they did not coexpress insulin (i.e., no yellow cells were observed in the merged image), suggesting that they represented normal differentiated ␣-cells. These results indicate that the abnormal islet morphology could contribute to the phenotype of the combined heterozygous mutant mice Pancreatic Gene Expression. To determine more precisely why ␤-cell function was compromised in Pdx-1 ϩ/Ϫ ͞Hnf-3␤
ϩ/Ϫ and Pdx-1 ϩ/Ϫ ͞Hnf-1␣ ϩ/Ϫ mice, steady-state mRNA profiles of transcription factors, hormones, and components of the glucosestimulated insulin secretion pathway that are essential for ␤-cell activity were generated by RT-PCR from Wt and mutant islet RNAs. Significant changes in expression from genes present in each effector category were identified in the combined heterozygous mutant mice (Fig. 4) .
Pdx-1 mRNA levels were moderately reduced in Hnf-3 ␤ animals by 38%, 41%, 65%, and 51%, respectively. These results are consistent with previous reports suggesting that Hnf-3␤ and Hnf-1␣ are regulators of Pdx-1 gene expression (10) (11) (12) (13) (14) (15) (Figs. 4 and 5) . Islet glucagon mRNA levels were similar in all mutants studied, supporting our immunohistological findings that indicated normal ␣-cell differentiation and similar ␣-cell to ␤-cell ratios between islets of Wt and various mutants.
Decreased insulin transcript levels (11% and 46%, respectively) were detected in Pdx-1 ϩ/Ϫ ͞Hnf-3␤ , indicating that a reduction in insulin gene transcription may contribute to the insulin secretion defect in these mice Fig. 4 ). In addition, we found a number of changes in the expression of genes that are responsible for glucose-stimulated insulin secretion. The expression of Glut-2 was reduced in Pdx-1 ϩ/Ϫ (35%, P Յ 0.05), Hnf-1␣
(37%, P Յ 0.05), and Pdx-1 ϩ/Ϫ ͞Hnf-1␣ ϩ/Ϫ (83%, P Յ 0.001) compared with wild-type animals, indicating that both Pdx-1 and Hnf-1␣, but not Hnf-3␤, are important regulators of Glut-2 expression. There was a synergistic effect on Glut-2 expression in mice that were haploinsufficient for both Pdx-1 and Hnf-1␣ genes. Liver pyruvate kinase mRNA levels were reduced in Hnf-1␣ ϩ/Ϫ animals and Hnf-1␣ ϩ/Ϫ ͞Pdx-1 ϩ/Ϫ mice, and the expression pattern correlates best with this gene being under the transcriptional control of Hnf-1␣ (Fig. 4) . Expression levels of the gene encoding Gck, which controls the rate-limiting step of glycolysis, were reduced in double-heterozygous mutants compared with Pdx-1 ϩ/Ϫ mice (56% and 52% for Pdx-1 ϩ/Ϫ ͞Hnf-3␤
ϩ/Ϫ
and Pdx-1 ϩ/Ϫ ͞Hnf-1␣ ϩ/Ϫ , respectively) (Fig. 4) . To identify genes that may contribute to the abnormal islet morphology in the double-heterozygous mice, we also investigated the expression levels of E-cadherin, a transmembrane domain glycoprotein that mediates cell-cell adhesion in the gastrointestinal tract and endocrine pancreas (19) . Interestingly, expression levels of E-cadherin were significantly reduced in
animals (44% and 48%, respectively), suggesting a possible role for cadherin in islet architecture of these mice (Fig. 4) .
As described above, compound-heterozygous
, and Hnf-1␣ ϩ/Ϫ ͞Hnf-4␣
ϩ/Ϫ mice do not have a worsened phenotype than is seen in single-mutant mice alone. These findings were surprising because heterozygous inactivation of HNF-4␣, like HNF-1␣, in humans is associated with the development of maturity-onset diabetes of the young. To study the possible mechanism(s) that confer(s) relative protection to the development of diabetes on an Hnf-4␣ ϩ/Ϫ genetic background we assayed gene expression in pancreatic islets of mice with one or two functional Hnf-4␣ alleles. We did not detect a significant down-regulation in expression of any islet-enriched transcription factors, including Hnf-4␣, or from genes involved in glucose-stimulated insulin secretion, such as Glut-2, Gck, liver pyruvate kinase, and aldolase B (data not shown). Moreover, known target genes of Hnf-4␣ such as aldo-B and Hnf-1␣ were not reduced in Hnf-4␣ ϩ/Ϫ mice compared with Wt animals. This is in contrast to our findings in Hnf-1␣ ϩ/Ϫ mice, which display reduced levels of Glut-2, liver pyruvate kinase, Hnf-4␣, Hnf-1␣, and Pdx-1 mRNA. Our results therefore suggest that, in mice, Hnf-4␣ can compensate for allelic loss by upregulating gene expression of the functional allele.
Discussion
Type 2 diabetes is a polygenic disease, and genetic predisposition to this condition is likely due to changes in expression and͞or activity of proteins important in insulin sensitivity and normal pancreatic islet function. However, a mutation in a susceptibility gene often does not result in diabetes unless present in combination with another, which together result in impaired glucose homeostasis. Such gene-gene interactions within the insulinsignaling pathway have been shown upon combining specific inactivating gene mutations in mice that are predisposed to insulin resistance (20) (21) (22) . For instance, plasma insulin levels increased by almost 50-fold in mice with combined haploinsufficiencies in the insulin receptor (Ir) and insulin receptor substrate-1 (Irs-1) genes, with Ϸ40% of the Ir ϩ/Ϫ ͞Irs-1 ϩ/Ϫ mice becoming overtly diabetic at 4-6 months of age (20) . Interestingly, islet mass was greatly expanded in these diabetic mice as a means of producing more insulin to aid in glucose clearance. Although the islet has clearly been shown to have a central role in regulating glucose homeostasis, little is known about how this process is influenced by epistatic interactions between factors critical for pancreatic ␤-cell function. In this study, we have shown that a combination of heterozygous deletions in certain subsets of the islet transcription factor network can act synergistically to cause diabetes.
Allelic loss of Hnf-1␣ and Hnf-3␤, although having no effect on glucose homeostasis as single mutants, markedly worsened the diabetic phenotype in Pdx-1 ϩ/Ϫ mice. Insulin secretion and blood glucose levels were compromised in both female and male double-mutant mice. These results are consistent with recent findings showing that Hnf-3␤ and Hnf-1␣ directly activate Pdx-1 transcription (10-15). Pdx-1 is a key effector of glucose sensing because of its action on Glut-2, insulin, and Gck expression. In contrast, we did not observe synergism between Hnf-3␣ or Hnf-4␣ with Pdx-1. mice exhibited decreased mRNA expression of specific factors involved in regulated islet gene transcription (Pdx-1, Nkx2.2, and Nkx6.1) and glucosestimulated insulin secretion signaling (Glut-2, Gck, L-Pk, and aldol-B) (Fig. 5) . Insulin message was also significantly decreased in the double-heterozygous mutant mice in which Pdx-1 expression was reduced by Ն50%. A reduction in Pdx-1 expression of Ն50% seems to be a critical threshold for causing a decrease in insulin gene mRNA levels. The insulin mRNA levels found in Pdx-1 ϩ/Ϫ islets (i.e., normal) and islets wherein Pdx-1 was selectively removed (i.e., reduced) also support our data (23) . Together, our findings illustrate that significant synergism exists between the Hnf-3␤, Hnf-1␣, and Pdx-1 transcription factors in regulating insulin gene transcription and expression of genes involved in glucose-stimulated insulin secretion.
To begin to address why ␤-cell function was not compro-
mice, gene expression profiles were generated with islet RNA from Wt and Hnf-4␣ ϩ/Ϫ mice. Interestingly, in contrast to the Hnf-1␣, Hnf-3␤, or Pdx-1 haploinsufficiency, the loss of an Hnf-4␣ allele did not significantly affect Hnf-4␣ mRNA expression levels as compared with the Wt. In addition, we did not find reduced expression of Pdx-1 or known targets of Hnf-4␣ (e.g., L-Pk, Hnf-1␣, and aldol-B). These results suggest that mechanism(s) exist, possibly through an autoregulatory feedback loop that can compensate for the loss of one Hnf-4␣ allele. Furthermore, our results also suggest that factors that do not significantly reduce Pdx-1 gene expression, such as Hnf-4␣ ϩ/Ϫ ͞Hnf-1␣ (data not shown), are less likely to affect ␤-cell activity.
To study whether allelic variation in Pdx-1, Hnf-3␤, and Hnf-1␣ affected islet development, a detailed morphological analysis was performed. We did not detect differences in islet size, although marked alterations in architecture were revealed by immunohistological analysis, with ␣-cells no longer confined to the islet periphery. However, the ␣-cells in doubleheterozygous mutant mice appeared to be functional (no differences in plasma glucagon levels were observed in mice of various genotypes) and present at the same relative ratio to ␤-cells as in Wt. As a change in islet morphology has also been noted in Nkx2.2, Nkx6.1, and Hnf-3␤-deficient mice (4, 24, 25) , the reduced expression levels of these genes in Pdx-1 ϩ/Ϫ ͞Hnf-3␤ ϩ/Ϫ and Pdx-1 ϩ/Ϫ ͞Hnf-1␣
ϩ/Ϫ mice may therefore contribute to this phenotype. In addition, the double heterozygous mice had reduced expression of E-cadherin. E-cadherin is important to regulate adhesion between all pancreatic endocrine cells and to maintain correct islet topology (19, 25) . Furthermore, the cellto-cell contacts mediated by E-cadherin have been shown to be required for insulin secretion in response to nutrient stimuli (26, 27) . Therefore, the reduced E-cadherin levels observed in the islets of double-mutant mice not only may lead to disorganized islets but also may contribute to impaired glucose tolerance.
In conclusion, we have created polygenic models for progressive pancreatic ␤-cell failure. Our results provide molecular insights of how subclinical, genetically predisposing defects in the pancreatic islet transcription network can synergize to develop progressive ␤-cell failure. Furthermore, these mutant mice provide unique models to dissect the epistatic interactions among different genes in complex pathways that regulate islet morphology and function, and to design specific therapeutic approaches that prevent ␤-cell failure.
